GILEAD SCIENCES, INC. Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax
GILEAD SCIENCES, INC. (GILD) reported Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax of $0 for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-09.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesTax · last filed 2018-05-09
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2017-12-31 was $0.00.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2017-09-30 was -$1.00M, a 200.00% decline year-over-year.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2016 was $8.00M, a 57.89% decline from fiscal 2015.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2015 was $19.00M, a 375.00% increase from fiscal 2014.
- GILEAD SCIENCES, INC. other comprehensive income (loss), reclassification adjustment from aoci on derivatives, tax for fiscal 2014 was $4.00M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 3 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 6 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 9 month as first filed | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 12 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-05-09 | -$1.00M derived: sum of 3 quarters · filed 2018-05-09 | -$1.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$1.00M derived: sum of 2 quarters · filed 2018-02-27 | -$1.00M derived: sum of 3 quarters · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 | ||||
| 2017-09-30 | -$1.00M 10-Q · filed 2017-11-07 | -$1.00M derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-07 | $1.00M 10-Q · filed 2017-08-07 | $1.00M derived: sum of 3 quarters · filed 2018-05-09 | $2.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2017-03-31 | $1.00M 10-Q · filed 2018-05-09 | $1.00M derived: sum of 2 quarters · filed 2018-05-09 | $2.00M derived: sum of 3 quarters · filed 2018-05-09 | $3.00M derived: sum of 4 quarters · filed 2018-05-09 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $1.00M derived: sum of 2 quarters · filed 2018-02-27 | $2.00M derived: sum of 3 quarters · filed 2018-02-27 | $8.00M 10-K · filed 2018-02-27 | ||||
| 2016-09-30 | $1.00M 10-Q · filed 2017-11-07 | $2.00M derived: sum of 2 quarters · filed 2017-11-07 | $8.00M 10-Q · filed 2017-11-07 | $13.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $1.00M 10-Q · filed 2017-08-07 | $7.00M 10-Q · filed 2017-08-07 | $12.00M derived: sum of 3 quarters · filed 2018-02-27 | $17.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $6.00M 10-Q · filed 2017-05-10 | $11.00M derived: sum of 2 quarters · filed 2018-02-27 | $16.00M derived: sum of 3 quarters · filed 2018-02-27 | $21.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $10.00M derived: sum of 2 quarters · filed 2018-02-27 | $15.00M derived: sum of 3 quarters · filed 2018-02-27 | $19.00M 10-K · filed 2018-02-27 | -$19.00M 10-K · filed 2016-02-24 | |||
| 2015-09-30 | $5.00M 10-Q · filed 2016-11-07 | $10.00M derived: sum of 2 quarters · filed 2016-11-07 | $14.00M 10-Q · filed 2016-11-07 | $15.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $5.00M 10-Q · filed 2016-08-05 | $9.00M 10-Q · filed 2016-08-05 | $10.00M derived: sum of 3 quarters · filed 2017-02-27 | $11.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $4.00M 10-Q · filed 2016-05-06 | $5.00M derived: sum of 2 quarters · filed 2017-02-27 | $6.00M derived: sum of 3 quarters · filed 2017-02-27 | $7.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $2.00M derived: sum of 2 quarters · filed 2017-02-27 | $3.00M derived: sum of 3 quarters · filed 2017-02-27 | $4.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $1.00M 10-Q · filed 2015-11-04 | $640.00K 10-Q · filed 2014-11-05 | $2.00M derived: sum of 2 quarters · filed 2015-11-04 | $3.00M 10-Q · filed 2015-11-04 | $2.70M 10-Q · filed 2014-11-05 | $1.39M derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-06-30 | $1.00M 10-Q · filed 2015-08-05 | -$1.07M 10-Q · filed 2014-08-04 | $2.00M 10-Q · filed 2015-08-05 | -$2.06M 10-Q · filed 2014-08-04 | $390.00K derived: sum of 3 quarters · filed 2016-02-24 | $748.00K derived: sum of 4 quarters · filed 2016-02-24 | ||
| 2014-03-31 | $1.00M 10-Q · filed 2015-05-08 | -$990.00K 10-Q · filed 2014-05-07 | -$610.00K derived: sum of 2 quarters · filed 2016-02-24 | -$252.00K derived: sum of 3 quarters · filed 2016-02-24 | -$493.00K derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | -$1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$1.25M derived: sum of 2 quarters · filed 2016-02-24 | -$1.49M derived: sum of 3 quarters · filed 2016-02-24 | -$1.00M 10-K · filed 2016-02-24 | $1.19M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | $358.00K 10-Q · filed 2014-11-05 | -$358.00K 10-Q · filed 2013-10-31 | $117.00K derived: sum of 2 quarters · filed 2014-11-05 | $610.00K 10-Q · filed 2014-11-05 | -$610.00K 10-Q · filed 2013-10-31 | $5.26M derived: sum of 4 quarters · filed 2015-02-25 | ||
| 2013-06-30 | -$241.00K 10-Q · filed 2014-08-04 | -$252.00K 10-Q · filed 2014-08-04 | $4.90M derived: sum of 3 quarters · filed 2015-02-25 | $3.14M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | -$11.00K 10-Q · filed 2014-05-07 | $5.14M derived: sum of 2 quarters · filed 2015-02-25 | $3.38M derived: sum of 3 quarters · filed 2015-02-25 | $2.84M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $5.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $3.40M derived: sum of 2 quarters · filed 2015-02-25 | $2.85M derived: sum of 3 quarters · filed 2015-02-25 | $2.00M 10-K · filed 2015-02-25 | $2.17M 10-K · filed 2014-02-25 | |||
| 2012-09-30 | -$1.76M 10-Q · filed 2013-10-31 | -$2.31M derived: sum of 2 quarters · filed 2013-10-31 | -$3.16M 10-Q · filed 2013-10-31 | |||||
| 2012-06-30 | -$548.00K 10-Q · filed 2013-08-01 | -$994.00K 10-Q · filed 2013-08-01 | ||||||
| 2011-12-31 | -$4.39M 10-K · filed 2014-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |